BlackRock’s Avidity Biosciences RNAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $927M | Buy |
|
|||||
|
2025
Q3 | $401M | Sell |
|
|||||
|
2025
Q2 | $265M | Sell |
|
|||||
|
2025
Q1 | $293M | Sell |
|
|||||
|
2024
Q4 | $289M | Buy |
|
|||||
|
2024
Q3 | $447M | Buy |
|
|||||
|
2024
Q2 | $352M | Buy |
|
|||||
|
2024
Q1 | $157M | Sell |
|
|||||
|
2023
Q4 | $58.8M | Buy |
|
|||||
|
2023
Q3 | $36.9M | Buy |
|
|||||
|
2023
Q2 | $63.9M | Buy |
|
|||||
|
2023
Q1 | $86.5M | Buy |
|
|||||
|
2022
Q4 | $117M | Buy |
|
|||||
|
2022
Q3 | $67.3M | Buy |
|
|||||
|
2022
Q2 | $57.1M | Buy |
|
|||||
|
2022
Q1 | $60.3M | Sell |
|
|||||
|
2021
Q4 | $78.4M | Buy |
|
|||||
|
2021
Q3 | $79.1M | Buy |
|
|||||
|
2021
Q2 | $66.7M | Buy |
|
|||||
|
2021
Q1 | $58.7M | Buy |
|
|||||
|
2020
Q4 | $51.8M | Buy |
|
|||||
|
2020
Q3 | $36.4M | Buy |
|
|||||
|
2020
Q2 | $17M | Buy |
|